Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
about
Enzymatic oxidative biodegradation of nanoparticles: mechanisms, significance and applicationsStem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An OverviewBioabsorbable polymers in cancer therapy: latest developmentsATM rs189037 (G > A) polymorphism and risk of lung cancer and head and neck cancer: A meta-analysisDiacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An UpdateAdvances in the use of nanocarriers for cancer diagnosis and treatmentAptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinomaPolyphenol-rich Avicennia marina leaf extracts induce apoptosis in human breast and liver cancer cells and in a nude mouse xenograft model.Preliminary study of mechanism of action of SN38 derivatives. Physicochemical data, evidence of interaction and alkylation of DNA octamer d(GCGATCGC)2.Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis.Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy.131I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma.Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancerNanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine.Preparation, characterization, and in vitro drug release behavior of glutathione-sensitive long-circulation micelles based on polyethylene glycol prodrug.A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects.Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.Image-guided tumor surgery: will there be a role for fluorescent nanoparticles?Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.Superseding the Hourglass Effect Toward the Successful Commercialization of Nanotechnology in the Medical Sciences - We Require a Change in PerspectiveIsolation, identification, and characterization of novel nanovesiclesDrug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting.pH-sensitive micelles self-assembled from polymer brush (PAE-g-cholesterol)-b-PEG-b-(PAE-g-cholesterol) for anticancer drug delivery and controlled release.Multifunctional nanoparticles: recent progress in cancer therapeutics.Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.Remote Control of Cellular Functions: The Role of Smart Nanomaterials in the Medicine of the Future.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Pancreas-Specific Delivery of β-Cell Proliferating Small Molecules.Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy.Gold nanoparticle surface functionalization: mixed monolayer versus hetero bifunctional peg linker.Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.Mechanisms of tumor cell resistance to the current targeted-therapy agents.
P2860
Q26345200-F6B35073-EB17-4470-8120-DE0D6D9A6AD2Q26770087-EB682446-61AC-4AE2-BD6D-962B9560C13EQ26775714-B96C59FD-9504-47E8-9950-8261987B584AQ26778613-9205C183-6F47-48B9-8D1C-893A7A8C2F6AQ28067133-16A2DAE5-3A7E-4A75-92B5-770050543750Q28070065-2D2AD620-D58C-449C-AD69-46AD562CCB6AQ28829736-A69334AF-7A5C-4E47-8ED2-6E34F24FC1C9Q31077129-1135ADF5-F27E-4C33-8AC4-B6ED508D8871Q31125490-0143E7CC-3449-44A9-8F21-9D97F11B321EQ33426343-0B67D024-E133-4642-8BEE-EE8A851A7890Q33553585-242D991A-F8AD-49C3-B82C-43E3106D4049Q33708363-1309A2F4-BF7D-469E-9092-B10F6159CB14Q33881254-B4C35C89-5EE7-40BE-8072-BD377260ECBCQ35767648-3CABE476-6C7E-4CE8-98E2-398001E15314Q35868588-5C931F3D-BB76-425B-9E0C-4791448534F6Q35893655-34FDA7E6-83FD-43F0-B3DB-A4BB673B9594Q35894545-E2840F07-83B1-42C8-A617-C50083C99939Q36352658-07111DB8-168C-411C-95F0-74C11BA6C094Q36392418-26794D83-73C0-448C-916C-08131C258ED8Q36685485-C9477007-B58B-41D0-B1ED-2FF2B4AA4E68Q36772217-77BB4D2B-BFF0-4C37-874F-44249BAA62A7Q36994932-2A83BCB6-BEC4-4C3E-9556-5888F8F79092Q37134029-AAD3972A-AE6D-45C0-AA86-AB5B328C7682Q37159109-FF719D23-E5D3-4A73-B687-A3EFEEDE9FCCQ37520226-811E7BD5-5BA2-4C58-92B8-1E09F591405FQ37639772-18C1A60E-A51E-4774-BA9C-D201E6B8A386Q37722704-3769674F-C4EB-4DF1-BA33-5CDD20B6B429Q38559193-4E867BCA-7AE1-4F40-B309-B3CC4823383DQ38658279-3588A6AD-4FAD-4ED6-A235-1087C20D9D33Q38670236-B076963E-4C6D-479E-A374-DA3DEFF5819DQ38723333-74B72DA5-424C-4596-BE38-A3500A913ED9Q38734711-E99CF7CA-1E15-46CE-A00D-0F978770199DQ38740502-9365037F-1AF0-4040-9FBA-386E610BE7FAQ38755295-513AE102-8949-4644-A5AC-FDB1281F07A1Q38776961-F893545D-8C30-4EAE-BAA1-C10FC5AF18F2Q38789551-5A479D53-1DC8-4871-A2EA-78C52FA5C011Q38791714-B91F2F87-F727-4434-B1E9-2DB4FA559891Q38806793-E18E574C-FE3E-4420-A3E6-66EEF9802EBAQ38810295-82A7BD9F-F4D5-457A-A7FA-ED33855514A8Q38828353-AF0F3E79-802F-4242-B2D8-EACFEA617938
P2860
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@ast
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@en
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@nl
type
label
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@ast
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@en
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@nl
prefLabel
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@ast
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@en
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@nl
P1476
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
@en
P2093
Alberto Fernández-Medarde
P356
10.1016/J.EJPB.2015.03.018
P407
P577
2015-03-23T00:00:00Z